{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:50:54Z","timestamp":1794887454282,"version":"4.9.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01174-1","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:52:15Z","timestamp":1749181935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox"],"prefix":"10.1038","volume":"10","author":[{"given":"Rahul","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaigham Abbas","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Maithil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Tarane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita Kumari","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Khalid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisek","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Priyadarsiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Mangala","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweety","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"crossref","unstructured":"Bankar, N. J. et al. Emerging and re-emerging viral infections: An Indian perspective. Cureus 14, e30062 (2022).","DOI":"10.7759\/cureus.30062"},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3201\/eid3005.230293","volume":"30","author":"C Besombes","year":"2024","unstructured":"Besombes, C. et al. Seasonal patterns of Mpox Index Cases, Africa, 1970-2021. Emerg. Infect. Dis. 30, 1017\u20131021 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13577-023-00870-1","volume":"36","author":"JPS Begum","year":"2023","unstructured":"Begum, J. P. S. et al. Emergence of monkeypox: a worldwide public health crisis. Hum. Cell 36, 877\u2013893 (2023).","journal-title":"Hum. Cell"},{"key":"1174_CR4","unstructured":"2022 Mpox Outbreak Global Map. Mpox, Poxvirus, CDC. https:\/\/www.cdc.gov\/poxvirus\/mpox\/response\/2022\/world-map.html."},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3201\/eid3001.231164","volume":"30","author":"EM Kibungu","year":"2024","unstructured":"Kibungu, E. M. et al. Clade I-associated mpox cases associated with sexual contact, the Democratic Republic of the Congo. Emerg. Infect. Dis. 30, 172\u2013176 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"1174_CR6","doi-asserted-by":"publisher","unstructured":"Nachega, J. B. et al. The surge of mpox in Africa: a call for action. Lancet Glob. Health https:\/\/doi.org\/10.1016\/S2214-109X(24)00187-6 (2024).","DOI":"10.1016\/S2214-109X(24)00187-6"},{"key":"1174_CR7","doi-asserted-by":"crossref","unstructured":"Moss, B. Poxvirus DNA replication. Cold Spring Harb. Perspect. Biol. 5, a010199 (2013).","DOI":"10.1101\/cshperspect.a010199"},{"key":"1174_CR8","unstructured":"Fields virology. WorldCat.org. https:\/\/search.worldcat.org\/title\/Fields-virology\/oclc\/71812790."},{"key":"1174_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov, S. N. et al. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66\u201370 (2001).","journal-title":"FEBS Lett."},{"key":"1174_CR10","doi-asserted-by":"crossref","unstructured":"Sammartino, J. C. et al. Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects. J. Med. Virol. 95, e28778 (2023).","DOI":"10.1002\/jmv.28778"},{"key":"1174_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41587-022-01463-3","volume":"40","author":"C Harrison","year":"2022","unstructured":"Harrison, C. Monkeypox response relies on three vaccine suppliers. Nat. Biotechnol. 40, 1306\u20131307 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1174_CR12","doi-asserted-by":"crossref","unstructured":"Chiuppesi, F. et al. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. Commun. Med. 4, 19 (2024).","DOI":"10.1038\/s43856-024-00443-9"},{"key":"1174_CR13","doi-asserted-by":"crossref","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med. 15, eadg3540 (2023).","DOI":"10.1126\/scitranslmed.adg3540"},{"key":"1174_CR14","doi-asserted-by":"crossref","unstructured":"Jacob-Dolan, C. et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci. Transl. Med. 16, eadl4317 (2024).","DOI":"10.1126\/scitranslmed.adl4317"},{"key":"1174_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1360586","volume":"14","author":"E Alakunle","year":"2024","unstructured":"Alakunle, E. et al. A comprehensive review of monkeypox virus and mpox characteristics. Front. Cell. Infect. Microbiol. 14, 1360586 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1174_CR16","unstructured":"Monkeypox: experts give virus variants new names. https:\/\/www.who.int\/news\/item\/12-08-2022-monkeypox--experts-give-virus-variants-new-names."},{"key":"1174_CR17","doi-asserted-by":"crossref","unstructured":"Yu, X., Shi, H. & Cheng, G. Mpox virus: its molecular evolution and potential impact on viral epidemiology. Viruses 15, 995 (2023).","DOI":"10.3390\/v15040995"},{"key":"1174_CR18","doi-asserted-by":"crossref","unstructured":"Lu, J. et al. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct. Target Ther. 8, 458 (2023).","DOI":"10.1038\/s41392-023-01675-2"},{"key":"1174_CR19","doi-asserted-by":"crossref","unstructured":"Garcia-Atutxa, I., Mondragon-Teran, P., Huerta-Saquero, A. & Villanueva-Flores, F. Advancements in monkeypox vaccines development: a critical review of emerging technologies. Front. Immunol. 15, (2024).","DOI":"10.3389\/fimmu.2024.1456060"},{"key":"1174_CR20","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yang, K. & Zhou, H. Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: a rapid review. Int. J. Biol. Macromol. 245, 125515 (2023).","DOI":"10.1016\/j.ijbiomac.2023.125515"},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/infdis\/jiq017","volume":"203","author":"LA Hirao","year":"2011","unstructured":"Hirao, L. A. et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J. Infect. Dis. 203, 95\u2013102 (2011).","journal-title":"J. Infect. Dis."},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","volume":"339","author":"CA Meseda","year":"2005","unstructured":"Meseda, C. A. et al. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Virology 339, 164\u2013175 (2005).","journal-title":"Virology"},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","volume":"28","author":"JW Hooper","year":"2009","unstructured":"Hooper, J. W. et al. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 28, 494 (2009).","journal-title":"Vaccine"},{"key":"1174_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","volume":"306","author":"JW Hooper","year":"2003","unstructured":"Hooper, J. W., Custer, D. M. & Thompson, E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306, 181 (2003).","journal-title":"Virology"},{"key":"1174_CR25","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/S0385-8146(85)80033-X","volume":"12","author":"N Kasai","year":"1985","unstructured":"Kasai, N., Sakamoto, A. & Uchida, M. A combined modality for anaplastic large-cell carcinoma of the thyroid. Auris Nasus Larynx 12, S72\u2013S74 (1985).","journal-title":"Auris Nasus Larynx"},{"key":"1174_CR26","doi-asserted-by":"crossref","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct. Target Ther. 8, 172 (2023).","DOI":"10.1038\/s41392-023-01432-5"},{"key":"1174_CR27","doi-asserted-by":"crossref","unstructured":"Chu, Q. et al. Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: evidence from mouse and rhesus monkey models. Emerg. Microbes Infect. 12, 2278900 (2023).","DOI":"10.1080\/22221751.2023.2278900"},{"key":"1174_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"BL Jacobs","year":"2009","unstructured":"Jacobs, B. L. et al. Vaccinia virus vaccines: past, present and future. Antivir. Res. 84, 1\u201313 (2009).","journal-title":"Antivir. Res."},{"key":"1174_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","volume":"239","author":"B Moss","year":"2011","unstructured":"Moss, B. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239, 8\u201326 (2011).","journal-title":"Immunol. Rev."},{"key":"1174_CR30","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1128\/JVI.00483-06","volume":"80","author":"D Su","year":"2006","unstructured":"Su, D. et al. Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J. Virol. 80, 7902\u20137908 (2006).","journal-title":"J. Virol."},{"key":"1174_CR31","doi-asserted-by":"crossref","unstructured":"Nguyen, B. & Tolia, N. H. Protein-based antigen presentation platforms for nanoparticle vaccines. npj Vaccines 6, 70 (2021).","DOI":"10.1038\/s41541-021-00330-7"},{"key":"1174_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-020-01400-6","volume":"19","author":"E Krachmarova","year":"2020","unstructured":"Krachmarova, E., Ivanov, I. & Nacheva, G. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma. Microb. Cell Factories 19, 1\u20139 (2020).","journal-title":"Microb. Cell Factories"},{"key":"1174_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh, S. M. & Panda, A. K. Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 99, 303\u2013310 (2005).","journal-title":"J. Biosci. Bioeng."},{"key":"1174_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1021\/bp970008l","volume":"13","author":"J Maachupalli-Reddy","year":"1997","unstructured":"Maachupalli-Reddy, J., Kelley, B. D. & De Bernardez Clark, E. Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol. Prog. 13, 144\u2013150 (1997).","journal-title":"Biotechnol. Prog."},{"key":"1174_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0014-5793(95)01437-3","volume":"378","author":"LR Castellanos-Serra","year":"1996","unstructured":"Castellanos-Serra, L. R. et al. Expression and folding of an interleukin-2-proinsulin fusion protein and its conversion into insulin by a single step enzymatic removal of the C-peptide and the N-terminal fused sequence. FEBS Lett. 378, 171\u2013176 (1996).","journal-title":"FEBS Lett."},{"key":"1174_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2400001","volume":"240","author":"FA Marston","year":"1986","unstructured":"Marston, F. A. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J. 240, 1\u201312 (1986).","journal-title":"Biochem J."},{"key":"1174_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0167-7799(88)90065-0","volume":"6","author":"JF Kane","year":"1988","unstructured":"Kane, J. F. & Hartley, D. L. Formation of recombinant protein inclusion bodies in Escherichia coli. Trends Biotechnol. 6, 95\u2013101 (1988).","journal-title":"Trends Biotechnol."},{"key":"1174_CR38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt1189-1141","volume":"7","author":"CH Schein","year":"1989","unstructured":"Schein, C. H. Production of soluble recombinant proteins in bacteria. Nat. Biotechnol. 7, 1141\u20131149 (1989).","journal-title":"Nat. Biotechnol."},{"key":"1174_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/femsre\/fuy038","volume":"43","author":"A De Marco","year":"2019","unstructured":"De Marco, A. et al. Bacterial inclusion bodies are industrially exploitable amyloids. FEMS Microbiol. Rev. 43, 53\u201372 (2019).","journal-title":"FEMS Microbiol. Rev."},{"key":"1174_CR40","doi-asserted-by":"publisher","first-page":"e00694","DOI":"10.1016\/j.btre.2021.e00694","volume":"33","author":"SD Ganjave","year":"2022","unstructured":"Ganjave, S. D., Dodia, H., Sunder, A. V., Madhu, S. & Wangikar, P. P. High cell density cultivation of E. coli in shake flasks for the production of recombinant proteins. Biotechnol. Rep. 33, e00694 (2022).","journal-title":"Biotechnol. Rep."},{"key":"1174_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-015-0155-y","volume":"5","author":"M Kangwa","year":"2015","unstructured":"Kangwa, M. et al. High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization. AMB Express 5, 1\u201310 (2015).","journal-title":"AMB Express"},{"key":"1174_CR42","first-page":"255","volume":"12","author":"S Honary","year":"2013","unstructured":"Honary, S. & Zahir, F. Effect of zeta potential on the properties of nano-drug delivery systems\u2014a review (Part 1). Trop. J. Pharm. Res. 12, 255\u2013264 (2013).","journal-title":"Trop. J. Pharm. Res."},{"key":"1174_CR43","doi-asserted-by":"crossref","unstructured":"Akbarian, M. & Chen, S. H. Instability challenges and stabilization strategies of pharmaceutical proteins. Pharmaceutics 14, 2533 (2022).","DOI":"10.3390\/pharmaceutics14112533"},{"key":"1174_CR44","doi-asserted-by":"crossref","unstructured":"N\u00e9meth, Z. et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics 14, 1798 (2022).","DOI":"10.3390\/pharmaceutics14091798"},{"key":"1174_CR45","doi-asserted-by":"crossref","unstructured":"Obata, T. et al. Effect of storage temperature on the dispersibility of commercially available 0.1% fluorometholone ophthalmic suspension. PLoS ONE 17, e0277311 (2022).","DOI":"10.1371\/journal.pone.0277311"},{"key":"1174_CR46","doi-asserted-by":"publisher","first-page":"14169","DOI":"10.1021\/acs.analchem.1c02814","volume":"93","author":"J Lee","year":"2021","unstructured":"Lee, J. et al. Combined effects of zeta-potential and temperature of nanopores on diffusioosmotic ion transport. Anal. Chem. 93, 14169\u201314177 (2021).","journal-title":"Anal. Chem."},{"key":"1174_CR47","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, T. et al. The effect of lipopolysaccharides from Salmonella enterica on the size, density, and compressibility of phospholipid vesicles. Biomimetics (Basel) 10, 55 (2025).","DOI":"10.3390\/biomimetics10010055"},{"key":"1174_CR48","doi-asserted-by":"publisher","unstructured":"Lakowicz, J. R. Principles of Fluorescence Spectroscopy 1\u2013954. https:\/\/doi.org\/10.1007\/978-0-387-46312-4\/COVER (2006).","DOI":"10.1007\/978-0-387-46312-4\/COVER"},{"key":"1174_CR49","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1016\/j.vaccine.2007.09.023","volume":"25","author":"M Sharon","year":"2007","unstructured":"Sharon, M. et al. Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice. Vaccine 25, 7743\u20137753 (2007).","journal-title":"Vaccine"},{"key":"1174_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/v15040905","volume":"15","author":"EA Falendysz","year":"2023","unstructured":"Falendysz, E. A., Lopera, J. G., Rocke, T. E. & Osorio, J. E. Monkeypox virus in animals: current knowledge of viral transmission and pathogenesis in wild animal reservoirs and captive animal models. Viruses 15, 905 (2023).","journal-title":"Viruses"},{"key":"1174_CR51","doi-asserted-by":"publisher","first-page":"25783","DOI":"10.1074\/jbc.M114.577353","volume":"289","author":"M Bouvet","year":"2014","unstructured":"Bouvet, M. et al. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J. Biol. Chem. 289, 25783\u201325796 (2014).","journal-title":"J. Biol. Chem."},{"key":"1174_CR52","doi-asserted-by":"publisher","first-page":"0310","DOI":"10.1371\/journal.ppat.0010039","volume":"1","author":"SG Sawicki","year":"2005","unstructured":"Sawicki, S. G. et al. Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog. 1, 0310\u20130322 (2005).","journal-title":"PLoS Pathog."},{"key":"1174_CR53","doi-asserted-by":"publisher","first-page":"4297937","DOI":"10.1155\/2020\/4297937","volume":"2020","author":"DC Carter","year":"2020","unstructured":"Carter, D. C., Wright, B., Jerome, W. G., Rose, J. P. & Wilson, E. A unique protein self-assembling nanoparticle with significant advantages in vaccine development and production. J. Nanomater. 2020, 4297937 (2020).","journal-title":"J. Nanomater."},{"key":"1174_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.46234\/ccdcw2024.025","volume":"6","author":"X Wang","year":"2024","unstructured":"Wang, X., Gu, Z., Sheng, S., Song, R. & Jin, R. The current state and progress of Mpox vaccine research. China CDC Wkly 6, 118\u2013125 (2024).","journal-title":"China CDC Wkly"},{"key":"1174_CR55","doi-asserted-by":"crossref","unstructured":"Shen-Gunther, J., Cai, H. & Wang, Y. Genomic and antigenic differences between monkeypox virus and vaccinia vaccines: insights and implications for vaccinology. Int. J. Mol. Sci. 26, 1428 (2025).","DOI":"10.3390\/ijms26041428"},{"key":"1174_CR56","doi-asserted-by":"crossref","unstructured":"Kupritz, J., Pahwa, S. & Pallikkuth, S. Serosurvey of immunity to monkeypox (Mpox) virus antigens in people living with HIV in South Florida. Pathogens 12, 1355 (2023).","DOI":"10.3390\/pathogens12111355"},{"key":"1174_CR57","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/bp00023a014","volume":"9","author":"P Valax","year":"1993","unstructured":"Valax, P. & Georgiou, G. Molecular characterization of beta-lactamase inclusion bodies produced in Escherichia coli. 1. Composition. Biotechnol. Prog. 9, 539\u2013547 (1993).","journal-title":"Biotechnol. Prog."},{"key":"1174_CR58","first-page":"110","volume":"5","author":"R Rudolph","year":"2008","unstructured":"Rudolph, R., Lilie, H. & Schwarz, E. In vitro folding of inclusion body proteins on an industrial scale. Biotechnology 5, 110\u2013123 (2008).","journal-title":"Biotechnology"},{"key":"1174_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1096\/fasebj.10.1.8566547","volume":"10","author":"R Rudolph","year":"1996","unstructured":"Rudolph, R. & Lilie, H. In vitro folding of inclusion body proteins. FASEB J. 10, 49\u201356 (1996).","journal-title":"FASEB J."},{"key":"1174_CR60","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nbt.4305","volume":"36","author":"G Walsh","year":"2018","unstructured":"Walsh, G. Biopharmaceutical benchmarks 2018. Nat. Biotechnol. 36, 1136\u20131145 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1174_CR61","doi-asserted-by":"publisher","first-page":"108050","DOI":"10.1016\/j.biotechadv.2022.108050","volume":"61","author":"L Buscajoni","year":"2022","unstructured":"Buscajoni, L., Martinetz, M. C., Berkemeyer, M. & Brocard, C. Refolding in the modern biopharmaceutical industry. Biotechnol. Adv. 61, 108050 (2022).","journal-title":"Biotechnol. Adv."},{"key":"1174_CR62","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.7036343","volume":"215","author":"DC Williams","year":"1982","unstructured":"Williams, D. C., Van Frank, R. M., Muth, W. L. & Burnett, J. P. Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. Science 215, 687\u2013689 (1982).","journal-title":"Science"},{"key":"1174_CR63","doi-asserted-by":"publisher","first-page":"108189","DOI":"10.1016\/j.bej.2021.108189","volume":"176","author":"D Mehta","year":"2021","unstructured":"Mehta, D., Chirmade, T., Tungekar, A. A., Gani, K. & Bhambure, R. Cloning and expression of antibody fragment (Fab) I: effect of expression construct and induction strategies on light and heavy chain gene expression. Biochem. Eng. J. 176, 108189 (2021).","journal-title":"Biochem. Eng. J."},{"key":"1174_CR64","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.procbio.2012.06.026","volume":"47","author":"YC Chen","year":"2012","unstructured":"Chen, Y. C., Lin, W. T., Wu, J. W. & Liu, H. S. Efficient lysozyme refolding at a high final concentration and a low dilution factor. Process Biochem. 47, 1883\u20131888 (2012).","journal-title":"Process Biochem."},{"key":"1174_CR65","doi-asserted-by":"crossref","unstructured":"Kang-Pettinger, T. et al. Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80. J. Biol. Chem. 299, 102769 (2023).","DOI":"10.1016\/j.jbc.2022.102769"},{"key":"1174_CR66","first-page":"347","volume":"8","author":"A Zhansaya","year":"2020","unstructured":"Zhansaya, A. et al. Recombinant expression and purification of extracellular domain of the programmed cell death protein receptor. Rep. Biochem. Mol. Biol. 8, 347 (2020).","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"1174_CR67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pep.2005.06.014","volume":"45","author":"CA Valente","year":"2006","unstructured":"Valente, C. A., Monteiro, G. A., Cabral, J. M. S., Fevereiro, M. & Prazeres, D. M. F. Optimization of the primary recovery of human interferon alpha2b from Escherichia coli inclusion bodies. Protein Expr. Purif. 45, 226\u2013234 (2006).","journal-title":"Protein Expr. Purif."},{"key":"1174_CR68","doi-asserted-by":"crossref","unstructured":"Mousavi, S. B. & Davarpanah, S. J. Solvent extraction of recombinant interferon alpha-2b from inclusion bodies and efficient refolding at high protein concentrations. Protein Expr. Purif. 197, 106110 (2022).","DOI":"10.1016\/j.pep.2022.106110"},{"key":"1174_CR69","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/diacare.4.1.64","volume":"4","author":"AD Riggs","year":"1981","unstructured":"Riggs, A. D. Bacterial production of human insulin. Diabetes Care 4, 64\u201368 (1981).","journal-title":"Diabetes Care"},{"key":"1174_CR70","doi-asserted-by":"publisher","first-page":"107764","DOI":"10.1016\/j.bej.2020.107764","volume":"164","author":"K Gani","year":"2020","unstructured":"Gani, K., Bhambure, R., Deulgaonkar, P., Mehta, D. & Kamble, M. Understanding unfolding and refolding of the antibody fragment (Fab). I. In-vitro study. Biochem. Eng. J. 164, 107764 (2020).","journal-title":"Biochem. Eng. J."},{"key":"1174_CR71","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/10826068.2014.985834","volume":"45","author":"AS Rathore","year":"2015","unstructured":"Rathore, A. S., Agarwal, H., Sharma, A. K., Pathak, M. & Muthukumar, S. Continuous processing for production of biopharmaceuticals. Prep. Biochem.Biotechnol. 45, 836\u2013849 (2015).","journal-title":"Prep. Biochem.Biotechnol."},{"key":"1174_CR72","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1021\/bi00175a035","volume":"33","author":"K Oberg","year":"1994","unstructured":"Oberg, K., Chrunyk, B. A., Wetzel, R. & Fink, A. L. Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR. Biochemistry 33, 2628\u20132634 (1994).","journal-title":"Biochemistry"},{"key":"1174_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2859-4-27","volume":"4","author":"E Garc\u00eda-Fruit\u00f3s","year":"2005","unstructured":"Garc\u00eda-Fruit\u00f3s, E. et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb. Cell Factories4, 1\u20136 (2005).","journal-title":"Microb. Cell Factories"},{"key":"1174_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tibtech.2006.02.007","volume":"24","author":"S Ventura","year":"2006","unstructured":"Ventura, S. & Villaverde, A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24, 179\u2013185 (2006).","journal-title":"Trends Biotechnol."},{"key":"1174_CR75","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jbiosc.2020.02.003","volume":"129","author":"R Lamm","year":"2020","unstructured":"Lamm, R. et al. Detailed small-scale characterization and scale-up of active YFP inclusion body production with Escherichia coli induced by a tetrameric coiled coil domain. J. Biosci. Bioeng. 129, 730\u2013740 (2020).","journal-title":"J. Biosci. Bioeng."},{"key":"1174_CR76","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s00253-017-8265-x","volume":"101","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli. Appl. Microbiol. Biotechnol. 101, 5267\u20135278 (2017).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1174_CR77","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0168-1656(99)00157-1","volume":"75","author":"AK Panda","year":"1999","unstructured":"Panda, A. K., Khan, R. H., Appa, Rao, K. B. C. & Totey, S. M. Kinetics of inclusion body production in batch and high cell density fed-batch culture of Escherichia coli expressing ovine growth hormone. J. Biotechnol. 75, 161\u2013172 (1999).","journal-title":"J. Biotechnol."},{"key":"1174_CR78","doi-asserted-by":"crossref","unstructured":"Yousaf, M., Ismail, S., Ullah, A. & Bibi, S. Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine. Front. Immunol. 13, 1035924 (2022).","DOI":"10.3389\/fimmu.2022.1035924"},{"key":"1174_CR79","doi-asserted-by":"crossref","unstructured":"Bhattacharya, M., Chatterjee, S., Nag, S., Dhama, K. & Chakraborty, C. Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: an immunoinformatics approach. Travel Med. Infect. Dis. 50, 102481 (2022).","DOI":"10.1016\/j.tmaid.2022.102481"},{"key":"1174_CR80","doi-asserted-by":"crossref","unstructured":"Waqas, M. et al. Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Front. Immunol. 14, 1091941 (2023).","DOI":"10.3389\/fimmu.2023.1091941"},{"key":"1174_CR81","doi-asserted-by":"publisher","first-page":"734","DOI":"10.4161\/hv.27316","volume":"10","author":"Q Zhao","year":"2014","unstructured":"Zhao, Q. et al. Characterization of virus-like particles in GARDASIL\u00ae by cryo transmission electron microscopy. Hum. Vaccines Immunother. 10, 734\u2013739 (2014).","journal-title":"Hum. Vaccines Immunother."},{"key":"1174_CR82","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.xphs.2022.07.019","volume":"111","author":"K Jerajani","year":"2022","unstructured":"Jerajani, K. et al. Analytical and preformulation characterization studies of human papillomavirus virus-like particles to enable quadrivalent multi-dose vaccine formulation development. J. Pharm. Sci. 111, 2983\u20132997 (2022).","journal-title":"J. Pharm. Sci."},{"key":"1174_CR83","doi-asserted-by":"crossref","unstructured":"Zeng, J. et al. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg. Microbes Infect. 12, 2204151 (2023).","DOI":"10.1080\/22221751.2023.2204151"},{"key":"1174_CR84","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187, 1363\u20131373.e12 (2024).","journal-title":"Cell"},{"key":"1174_CR85","doi-asserted-by":"crossref","unstructured":"Grigoryan, L. et al. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice. npj Vaccines 7, 55 (2022).","DOI":"10.1038\/s41541-022-00472-2"},{"key":"1174_CR86","doi-asserted-by":"crossref","unstructured":"Yadav, N. et al. Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen in vivo. Microbes Infect. 23, 104843 (2021).","DOI":"10.1016\/j.micinf.2021.104843"},{"key":"1174_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"V Kumar","year":"2021","unstructured":"Kumar, V., Kumar, R., Jain, V. K. & Nagpal, S. Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity. Sci. Rep. 11, 1\u201314 (2021).","journal-title":"Sci. Rep."},{"key":"1174_CR88","doi-asserted-by":"crossref","unstructured":"Kumar, V., Wadhwa, R., Kumar, N. & Maurya, P. K. A comparative study of chemically synthesized and Camellia sinensis leaf extract-mediated silver nanoparticles. 3 Biotech 9, 7 (2019).","DOI":"10.1007\/s13205-018-1544-0"},{"key":"1174_CR89","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"1174_CR90","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"1174_CR91","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"1174_CR92","doi-asserted-by":"publisher","first-page":"e18924","DOI":"10.1371\/journal.pone.0018924","volume":"6","author":"BEF Mota","year":"2011","unstructured":"Mota, B. E. F. et al. Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus. PLoS ONE 6, e18924 (2011).","journal-title":"PLoS ONE"},{"key":"1174_CR93","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/315190","volume":"181","author":"M Bray","year":"2000","unstructured":"Bray, M. et al. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J. Infect. Dis. 181, 10\u201319 (2000).","journal-title":"J. Infect. Dis."},{"key":"1174_CR94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-1-4939-9148-8_23","volume":"1955","author":"NI Medeiros","year":"2019","unstructured":"Medeiros, N. I. & Gomes, J. A. S. Cytometric bead array (CBA) for measuring cytokine levels in Chagas disease patients. Methods Mol. Biol. 1955, 309\u2013314 (2019).","journal-title":"Methods Mol. Biol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01174-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:03:33Z","timestamp":1749197013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01174-1","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Translational Health Science and Technology Institute (THSTI) has filed patent PCT International Application No. PCT\/IB2022\/059713||202111046243|| Multiepitope Self-Assembled Nanoparticle vaccine platform (msn-vaccine platform) and uses thereof, and listed S.S., S.A., R.K., and A.A., and technology has been transferred to Panacea Biotec Ltd, India for development of DP and DS. Indian Patent Provisional Application No.: 202411072889 filed on September 26, 2024, Title: an engineered polypeptide complex for generating protective immune responses against monkeypox (MPXV). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}